NCT00211328View on ClinicalTrials.gov

Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

March 31, 2007

Conditions
Idiopathic Perifoveal Telangiectasia
Interventions
DRUG

anecortave acetate

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Manhattan Eye, Ear & Throat Hospital

OTHER